Spectrum Pharmaceuticals, Inc. Blog | Talkmarkets | Page 1
No data available
No data available

People who follow this stock (37)

Latest Posts

About This Stock More About This Stock
Spectrum Pharma Analyst Says Sell-Off May Have Been Overdone
Article By: Benzinga
Friday, December 27, 2019 4:23 PM EDT
B Riley FBR analyst Mayank Mamtani maintained a Buy rating on Spectrum and lowered the price target from $18 to $11.
In this article: SPPI
Week In Review: China Pharmas Announce Deals Worth $1.5 Billion
Article By: ChinaBio® Today
Saturday, December 8, 2018 4:21 PM EDT
WuXi AppTec, China's largest CRO/CMO, completed a $1 billion IPO on the Hong Kong markets, pricing the offering in the middle of the expected range (see story). In May, WuXi became a public company by completing a $328 million IPO in Shanghai.
In this article: RVNC, VBIV, CASI, SPPI
Spectrum (SPPI) Earnings And Sales Beat Estimates In Q1
Article By: Zacks Investment Research
Saturday, May 5, 2018 9:05 PM EDT
Spectrum Pharma’s shares have underperformed the industry so far this year. The stock has lost 16.5% against the industry’s decline of 5%. Plus more news on Amgen, Ligand Pharmaceuticals and Protagonist Therapeutics.
In this article: SPPI, AMGN, LGND, PTGX
The World’s Most Expensive Drug ($1,210,000/dose) From UniQure B.V. Will Soon Become Extinct
Article By: Lorimer Wilson
Thursday, April 20, 2017 11:24 AM EDT
The world’s most expensive drug, from UniQure,. will soon become extinct. Here is a list of the top 10; #10 on the list still costs $450,540.
In this article: SPPI, QURE Also: SNY, ALXN, BMRN, HZNP, BIVV
3 Drug Stocks That Could Benefit From Key FDA Events In Sep. 2016
Article By: Arpita Dutt
Monday, September 12, 2016 1:25 PM EDT
The drug development process is often lengthy and time-consuming and requires the utilization of a lot of funds and resources. It may well take a drug anything between 10-12 years to be successfully developed and reach the market.
In this article: VRTX, AMGN, SPPI Also: ABBV


Latest Tweets for $SPPI

No tweets yet!